Log in to save to my catalogue

Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient

Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d61edc8bae2d4d3c8f29f4fd3b6b89ba

Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient

About this item

Full title

Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2023-04, Vol.14 (1), p.1999-1999, Article 1999

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Monoclonal antibodies (mAbs) directed against the spike of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are effective therapeutic options to combat infections in high-risk patients. Here, we report the adaptation of SARS-CoV-2 to the mAb cocktail REGN-COV in a kidney transplant patient with hypogammaglobulinemia. Following mAb treat...

Alternative Titles

Full title

Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d61edc8bae2d4d3c8f29f4fd3b6b89ba

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d61edc8bae2d4d3c8f29f4fd3b6b89ba

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-023-37591-w

How to access this item